Rational design of multitarget-directed ligands: strategies and emerging paradigms

J Zhou, X Jiang, S He, H Jiang, F Feng… - Journal of medicinal …, 2019 - ACS Publications
Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit
satisfactory efficacy. Recently, increasing evidence indicates that simultaneous modulation …

Anti-cancer activity of derivatives of 1, 3, 4-oxadiazole

T Glomb, K Szymankiewicz, P Świątek - Molecules, 2018 - mdpi.com
Compounds containing 1, 3, 4-oxadiazole ring in their structure are characterised by
multidirectional biological activity. Their anti-proliferative effects associated with various …

Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents

SA El-Metwally, MM Abou-El-Regal, IH Eissa… - Bioorganic …, 2021 - Elsevier
Vascular endothelial growth factor-2 (VEGFR-2) is considered one of the most important
factors in tumor angiogenesis, and consequently a number of anticancer therapeutics have …

Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies

M Moradi, A Mousavi, Z Emamgholipour… - European Journal of …, 2023 - Elsevier
Angiogenesis, the formation of new blood vessels from the existing vasculature, is pivotal in
the migration, growth, and differentiation of endothelial cells in normal physiological …

Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment

X Peng, Z Sun, P Kuang, J Chen - European Journal of Medicinal Chemistry, 2020 - Elsevier
Histone deacetylases (HDACs) are a class of enzymes that remove acetyl from the ε-N-
acetyl lysine of histones, allowing histones to wrap DNA more tightly. HDACs play an …

Multitargeted platinum (IV) anticancer complexes bearing pyridinyl ligands as axial leaving groups

Q Zhou, S Chen, Z Xu, G Liu, S Zhang… - Angewandte Chemie …, 2023 - Wiley Online Library
Although multitargeted PtIV anticancer prodrugs have shown significant activities in
reducing drug resistance, the types of bioactive ligands and drugs that can be conjugated to …

Therapeutic progression of quinazolines as targeted chemotherapeutic agents

R Bansal, A Malhotra - European Journal of Medicinal Chemistry, 2021 - Elsevier
Presently cancer is a grave health issue with predominance beyond restrictions. It can affect
any organ of the body. Most of the available chemotherapeutic drugs are highly toxic, not …

[HTML][HTML] Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds

H Liu, W Qiu, T Sun, L Wang, C Du, Y Hu, W Liu… - … Pharmaceutica Sinica B, 2022 - Elsevier
Glioblastoma (GBM) is the most common aggressive malignant tumor in brain
neuroepithelial tumors and remains incurable. A variety of treatment options are currently …

Medicinal chemistry of quinazolines as anticancer agents targeting tyrosine kinases

MF Zayed - Scientia Pharmaceutica, 2023 - mdpi.com
Cancer is a large group of diseases that can affect any organ or body tissue due to the
abnormal cellular growth with the unknown reasons. Many of the existing chemotherapeutic …

An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis

SA Ansar, S Aggarwal, S Arya, MA Haq, V Mittal… - Scientific reports, 2023 - nature.com
Malignant cancer angiogenesis has historically attracted enormous scientific attention.
Although angiogenesis is requisite for a child's development and conducive to tissue …